15 firms writing Biotech checks in Boston, led by Sofinnova Investments, Atlas Venture, Casdin Capital — ranked by verified deal count with the companies.
Biotech in Boston accounts for 34 tracked companies with verified cap-table data, 34 of which disclose round sizes totalling $7.7B. The median disclosed raise is $144M, and the largest is Kailera Therapeutics at $1.6B, ahead of Odyssey Therapeutics ($726M) and Astria Therapeutics ($700M).
The names that recur most often on these biotech cap tables are Alexandria Venture Investments (5 companies), Cormorant Asset Management (5 companies), Janus Henderson Investors (5 companies), Atlas Venture (4 companies), ARCH Venture Partners (4 companies), Sanofi Ventures (4 companies). By latest disclosed round, the market skews Series A (19), Series B (7), Series D (2), Growth (2).
All research · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide